S 4348 Prescription Drug User Fee Amendments of 2022 Medical Device User Fee Amendments of 2022 Biosimilar User Fee Amendments of 2022 Food and Drug Administration Safety and Landmark Advancements Act of 2022 Modernization of Cosmetics Regulation Act of 2022 Verifying Accurate Leading edge IVCT Development Act of 2022 Generic Drug User Fee Amendments of 2022 VALID Act of 2022
US Congress 117th Congress
Prescription Drug User Fee Amendments of 2022 Medical Device User Fee Amendments of 2022 Biosimilar User Fee Amendments of 2022 Food and Drug Administration Safety and Landmark Advancements Act of 2022 Modernization of Cosmetics Regulation Act of 2022 Verifying Accurate Leading-edge IVCT Development Act of 2022 Generic Drug User Fee Amendments of 2022 VALID Act of 2022
S.4348
About S.4348
A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, and for other purposes.
Bill Texts
Introduced 07/14/2022
Introduced 06/01/2022
Weigh In
No votes yet!
Cast yours now to be the first.
Votes for: 0 Votes against: 0
Spread the Word!
Gettr
Sponsors (2)
